Under the scientific leadership of PD Dr. med. Heather Dawson (Universitätsspital Bern) and PD Dr. med. Peter Bode (Kantonsspital Winterthur), experts will meet in Zurich to discuss emerging biomarker-guided therapies in a nutshell, highlighting the latest clinical developments and their practical implications across genitourinary, gastrointestinal, lung, and breast cancers.

Chairs

PD Dr. med. Heather Dawson, Universitätsspital Bern and PD Dr. med. Peter Bode, Kantonsspital Winterthur

Experts

GU: Prof. Dr. med. Arnoud Templeton (St. Claraspital Basel) and PD Dr. med. Niels Rupp (Pathologie Medica Enge)

GI: PD Dr. med. Alexander Siebenhüner (Klinik für Hämatologie und Onkologie) and PD Dr. med. Heather Dawson (Universitätsspital Bern)

Lung: PD Dr. med. Sabine Schmid (Universitätsspital Bern) and PD Dr. med. Sabina Berezowska (CHUV)

Breast: Prof. Dr. med. Cornelia Leo (Kantonsspital Baden) and Prof. Dr. med. Aurelia Noske (Pathologie Medica Enge)

Programme

17:00 – 17:05h: Welcome

17:05 – 17:45h: Update in biomarker-guided therapies in GU Cancer

17:45 – 18:25h: Update in biomarker-guided therapies in GI Cancer

18:25 – 18:35h: Break

18:35 – 19:15h: Update in biomarker-guided therapies in Lung Cancer

19:15 – 19:55h: Update in biomarker-guided therapies in Breast Cancer

19:55 – 20:00h: Wrap-Up & Take-Home Messages

Venue

Zunfthaus zur Zimmerleuten

Limmatquai 40

8001 Zurich

CME Credits

CME accreditation will be requested for this event.

Registration

Participation is free of charge. Registration exclusively for healthcare professionals.

We look forward to welcoming you at PathOnConnect 2027!